CHRT503-2021-22 -DS/DN - Greater Manchester Pharmacy Logistics Supply Chain Service
key details
| Value | £7,100,000,000 |
|---|---|
| Status | cancelled |
| Category (CPV) | 33600000 +8 more |
| Region | North West |
| Deadline | 8 Apr 2022 |
| Procedure | selective |
| OCID | ocds-h6vhtk-03200d |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| not named | · | · | unsuccessful |
description
The Christie NHS Foundation Trust (“Trust”), on behalf of itself and the other NHS organisations within the Greater Manchester Provider Chief Pharmacists’ Collaborative (GMPCPC) identified within this notice, would like to invite potential suppliers to participate in a tender process for the provision of regional medicine supply chain services.
The GMPCPC was tasked to improve service levels and increase medicines optimisation activities and has identified, as the most effective option, a regional supply chain model that provides medicines at pre-assembled ward level to hospitals.
The Trust and Authorised Service Recipients require safe, reliable and resilient medicines supply chain Services, to drive efficiencies and streamline all logistics processes.
The Trust will act as host organisation of the operating model, across procurement, implementation and ongoing operations. The Trust will operate a strategic Control Tower, which will be co-located at the Facility and act as intermediary between the successful Supplier and the Authorised Service Recipients.
Each potential supplier will be required to identify and confirm within its bid the medicines it has access to under CMU contracts (known as Standard Stock). The successful Supplier will then be responsible for all Standard Stock medicine procurement, ownership and supply chain management.
All other medicines required to fulfil Orders from Authorised Service Recipients (known as Non-Standard Stock) will be purchased on behalf of the Authorised Service Recipients by the Control Tower. Whilst the successful Supplier will not take ownership of the Non-Standard Stock, it will be required to store, pick, pack and deliver (i.e. provide supply chain management for) that Non-Standard Stock together with all Standard Stock.
The value of the contract opportunity stated in this notice includes the potential cost of all Standard Stock to be provided by the successful Supplier.
The successful Supplier will be responsible for all storage and management of Stock, preparation of Stock for transportation and delivery, minimisation of Stock wastage, and delivery of Stock from the Facility to the Delivery Points.
The successful Supplier is required to provide an electronic inventory management system (known as the Dedicated IT) to underpin the procurement, inventory, Ordering, delivery and invoicing of Stock. Other technologies such as cumulative barcoding, GS1 and business intelligence provision are required as part of the Services.
In accordance with the requirements of the Service Contract, changes to medicines regulations, developments and innovations are to be considered, anticipated and incorporated into the model over the Term.
The Trust’s ambition is to build a collaborative relationship with the successful Supplier, and to create a forward thinking and intelligent structure to anticipate and satisfy the developing needs of the pharmacy services in Greater Manchester.
All capitalised terms used in this short description have the meaning given to them in the procurement documents.
Tenderers are strongly encouraged to consider the procurement documents in full to ensure that they are able to understand and appreciate the entire scope of the opportunity
documents
- https://www.contractsfinder.service.gov.uk/Notice/f2eef6d6-07e8-44c7-a538-c63ef78ec374 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 9 Mar 2022 | Contract notice (F02) | Earlier regulations | 006515-2022 |
| 9 Mar 2022 | Tender (tender) | · | f2eef6d6-07e8-44c7-a538-c63ef78ec374-517098 |
| 11 Aug 2022 | Contract award notice (F03) | Earlier regulations | 022153-2022 |
more from The Christie NHS Foundation Trust
- Siemens Somatom Maintenance · £223,039 · 30 Jul 2026
- Aseptic Suite & Dispensary Works - Architect & Principal Designer (Stage 0-3) · £43,951 · 28 Jul 2026
- Radiopharmaceutical Products - Poltech · £39,000 · 28 Jul 2026
- C-Arm - OEC One: Maintenance · £58,013 · 24 Jul 2026
- Ward 10 Refurbishment - Architect & Principal Designer · £56,400 · 24 Jul 2026
- Project Management Service to support Network Refresh Programme · £73,600 · 24 Jul 2026
- Sitewide Macerator upgrade · £30,890 · 24 Jul 2026
- Fire Door Survey · £220,000 · 23 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.